TARS
TARS
US87650L1035
Tarsus Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 451.360.000 182.953.000
146.7%
Cost of Revenue 30.684.000 12.826.000
139.2%
Gross Profit 420.676.000 170.127.000
147.3%
491.645.000 290.696.000
69.1%
Operating Income -70.969.000 -120.569.000
41.1%
Pretax Income -64.359.000 -115.554.000
44.3%
Net Income Common Stockholders -66.418.000 -115.554.000
42.5%
-- --
--
-- --
--
ende